Targeted regulation of autophagy using sorafenib-loaded biomineralization nanoenzyme for enhanced photodynamic therapy of hepatoma
Open Access
- 24 September 2024
- journal article
- research article
- Published by Elsevier in Materials Today Bio
- Vol. 29, 101270
Abstract
No abstract availableKeywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
This publication has 47 references indexed in Scilit:
- Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular CarcinomaJAMA Oncology, 2023
- ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosisArchives of Toxicology, 2023
- Reactive oxygen species-powered cancer immunotherapy: Current status and challengesJournal of Controlled Release, 2023
- Self-delivery biomedicine for enhanced photodynamic therapy by feedback promotion of tumor autophagyActa Biomaterialia, 2023
- Folic acid-modified bovine serum albumin nanoparticles with doxorubicin and chlorin e6 for effective combinational chemo-photodynamic therapyMaterials Science and Engineering: C, 2020
- Monitoring Autophagy Flux and Activity: Principles and ApplicationsBioEssays, 2020
- Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future developmentActa Pharmaceutica Sinica B, 2020
- Improved enzymatic assay for hydrogen peroxide and glucose by exploiting the enzyme-mimicking properties of BSA-coated platinum nanoparticlesMicrochimica Acta, 2019
- Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor ImmunityAdvanced Materials, 2017
- HIF-1α pathway: role, regulation and intervention for cancer therapyActa Pharmaceutica Sinica B, 2015